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Background: We reported a case of sudden monocular vision loss after calcium hydroxyapatite (CaHA) injection
into the nasal tip and dorsum with detailed retina images.
Case presentation: A healthy, 35-year-old woman received CaHA filler injection for nose augmentation. Ten minutes
after the procedure, she developed nausea, vomiting, headache, ptosis, and left periorbital pain. After 30 minutes, she
complained of progressively blurring vision in the left eye. The best-corrected visual acuity (BCVA) in her left eye was
30 cm ahead of hand motion. Left exotropia was noted in primary gaze. Limitations in adduction, supraduction, and
infraduction of the left eye were also observed. Slit lamp examination of the left eye revealed a pink conjunctiva, a clear
cornea, a mild anterior chamber reaction, a sluggish papillary light reflex, and a semi-dilated pupil. A positive relative
afferent pupillary defect was observed in the left eye. Fundus examination revealed optic disc edema and some linear
whitish opacity over the superior and temporal sites in the left eye, suggesting multiple CaHA emboli in the choroid
vessels.
Conclusions: Although the majority of adverse reactions are mild and transient, surgeons should be alert about
extremely rare serious adverse events such as visual loss.
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Facial plastic surgery reverses the signs of aging. Injectable fa-
cial fillers are effective in ameliorating certain signs of aging
[1], and calcium hydroxyapatite (CaHA) is one of the most
commonly used fillers for this purpose [2]. Serious adverse
events are rarely observed, and the majority of adverse reac-
tions are mild and transient [3]. Here we report the case of a
35-year-old woman who developed sudden monocular vision
loss after CaHA injection into the nasal tip and dorsum.Case presentation
A healthy, 35-year-old woman without any history of
ocular and systemic disease received CaHA filler injections* Correspondence: irisluu2396@gmail.com
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Multiple injections along midline of the nasal dorsum from
nasal tip to glabella were performed under local anesthesia.
Ten minutes after the procedure, she developed nausea,
vomiting, headache, ptosis, and left periorbital pain. After
30 minutes, she complained of progressively blurring
vision in the left eye. The best-corrected visual acuity
(BCVA) in her left eye was 30 cm ahead of hand motion.
Skin necrosis developed over the nasal dorsum, glabellar
region, and left forehead (Figure 1a). Left exotropia was
noted in primary gaze. Limitations in adduction, supraduc-
tion, and infraduction of the left eye were also observed
(Figure 1b). Slit lamp examination of the left eye revealed a
pink conjunctiva, a clear cornea, a mild anterior chamber
reaction, a sluggish pupillary light reflex, and a semi-
dilated pupil. A positive relative afferent pupillary defect
was observed in the left eye. The intraocular pressure was
normal in both eyes. Fundus examination revealed optic
disc edema and some linear whitish opacities over thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Skin necrosis developed at nasal dorsum, glabellar region, and left forehead (a). Left exotropia was noted in primary gaze, and
limitations on adduction, supraduction, and infraduction in left eye were also noted (b).
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tiple CaHA emboli in the choroid vessels (Figure 2a,b).
Optical coherence tomography (OCT) revealed disc edema
without macular edema in the left eye (Figure 2c).
Fluorescein angiography revealed neither delayed filling
nor hypofluroescence in the left eye. Visual field testing
revealed an inferior altitudinal visual field defect in the left
eye. Measurement of the visual evoked potential (VEP)
showed a decreased amplitude and marked delay in the
appearance of peaks. Electroretinography (ERG) showed a
normal waveform. All examinations were normal in the
right eye. Orbital computed tomography (CT) demon-
strated high-density deposits in the nose region and left
medial orbital cavity (Figure 3). No evident lesion was
noted on brain magnetic resonance imaging (MRI).
Alprostadil and dextran were administered for improv-
ing blood supply. Moreover, ten sessions of hyperbaric
oxygen therapy were administered. One month later, the
visual acuity in her left eye improved to 6/60. A pale disc
was observed, with persistent plaque occlusions in the
choroid vessels.
Discussion
There are few reports of vision loss following facial
injection of autologous fat or hyaluronic acid [4-6]. In
a previous study, Lazzeri et al. [7] reported 32 cases
of blindness caused by iatrogenic retinal embolismFigure 2 Fundus examination revealed optic disc edema and some lin
left eye, suggesting multiple CaHA emboli in the choroid vessels (a).
or OCT (c).after cosmetic facial filler injections, while Park et al.
[8] reported 12 cases of retinal artery occlusion
caused by cosmetic facial filler injections. Further-
more, Park et al. [9] showed the clinical and angio-
graphic features of occlusion of the ophthalmic artery
and its branches caused by cosmetic facial filler injec-
tions. In these 44 cases, only one was attributed to
CaHA, and no CaHA emboli were clearly observed on
fundus photography.
Sung et al. [10] postulated that emboli may move in a
retrograde fashion to the ophthalmic artery under a high
injection pressure. In the present case, multiple emboli
localized on the choroidal layer without retinal vessel oc-
clusion, resulting in normal ERG waveform. However,
poor vision, a positive RAPD sign, and a pale, swollen
disc were present. Visual field testing showed an inferior
altitudinal visual field defect. We postulate that the
CaHA emboli migrated via the dorsonasal artery back to
the main ciliary arteries and occluded the short posterior
ciliary arteries, which supply the superior nasal choroid
and the optic nerve. Subsequently, ischemic optic neur-
opathy developed and caused poor vision, a positive
RAPD sign, a pale, swollen disc, and an abnormal wave-
form on VEP. Furthermore, we first postulated that the
occluded vessel was Haller’s layer because the distribu-
tion pattern of affected vessels was consistent with the
Haller’s layer distribution pattern.ear whitish opacities over the superior and temporal sites in the
No macular edema in left eye was revealed on fundus examination (b),
Figure 3 Orbital CT demonstrates multiple radiopaque spots in
the subcutaneous layer of medial aspect of left periorbital
region, suggesting CaHA deposition.
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oculomotor nerve, causing blepheroptosis and ophtalmo-
plegia. This is compatible with the CT findings (Figure 3).
The ptosis and limitation in supraduction subsided
gradually. We postulate that the superior division of the
oculomotor nerve innervating the levator and superior
rectus muscles recovered early.
In previously reported cases of CaHA injections and in
this case, there was no cerebral infarction, which is more
frequently observed after autologous fat injections [9].
This may be related to properties of the filler material,
such as molecular weight or size.
To decrease the risk of intravascular injection and
retrograde occlusion, Park et al. suggested slow injection
in a fractionated dose and the use of a blunt cannula [9].
We suggest the use of a mixture of CaHA and epineph-
rine because epinephrine leads to vasoconstriction and
thus decreases the possibility of intravascular injection.
Soft tissue can be dissected to create a subcutaneous
space for subsequent filler injection. Furthermore, an injec-
tion device with a valve that can relieve excessive injection
pressure can be designed for this purpose.
Injectable facial fillers have become increasingly popular
these days. Although the majority of adverse reactions are
mild and transient, surgeons should be alert about ex-
tremely rare serious adverse events such as visual loss.
Most cases of blindness are caused by autologous fat and
hyaluronic acid injections. To the best of our knowledge,
localized choroid vascular occlusion, ischemic optic neur-
opathy, and cranial nerve III palsy without evidence of
compromised retinal or choroidal circulation after CaHA
injection have not been reported.
Conclusion
In conclusion, we reported a case of sudden monocular
vision loss after CaHA filler injection into the nasal
tip and dorsum. CaHA emboli were clearly observed
in this case, providing direct evidence to prove the
mechanism underlying retrograde occlusion after fa-
cial filler injection.Consent statement
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